Gross Profit Margin (Quarterly) Chart

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 1997. Start Trial.
Date Value
July 31, 2026 60.80%
April 30, 2026 61.10%
January 31, 2026 59.81%
October 31, 2025 60.45%
July 31, 2025 59.63%
April 30, 2025 58.49%
January 31, 2025 61.31%
October 31, 2024 59.91%
July 31, 2024 59.53%
April 30, 2024 60.51%
January 31, 2024 60.33%
October 31, 2023 60.10%
July 31, 2023 60.45%
April 30, 2023 60.39%
January 31, 2023 59.86%
October 31, 2022 61.28%
July 31, 2022 60.39%
April 30, 2022 62.91%
January 31, 2022 63.09%
October 31, 2021 63.08%
July 31, 2021 62.43%
April 30, 2021 62.57%
January 31, 2021 60.93%
October 31, 2020 59.25%
July 31, 2020 55.16%
Date Value
April 30, 2020 55.57%
January 31, 2020 63.90%
October 31, 2019 63.63%
July 31, 2019 62.94%
April 30, 2019 64.56%
January 31, 2019 64.48%
October 31, 2018 64.90%
July 31, 2018 64.31%
April 30, 2018 65.24%
January 31, 2018 64.15%
October 31, 2017 63.36%
July 31, 2017 62.26%
April 30, 2017 62.96%
January 31, 2017 62.03%
October 31, 2016 61.52%
July 31, 2016 61.65%
April 30, 2016 62.28%
January 31, 2016 62.27%
October 31, 2015 62.45%
July 31, 2015 59.91%
April 30, 2015 54.11%
January 31, 2015 72.58%
October 31, 2014 71.90%
July 31, 2014 72.31%
April 30, 2014 72.47%

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks
Start Trial
Abbott Laboratories 52.64%
Becton, Dickinson & Co. 46.46%
Boston Scientific Corp. 66.50%
Intuitive Surgical, Inc. 67.76%
Johnson & Johnson 68.73%

Gross Profit Margin (Quarterly) Related Metrics